Aussie tech startup acquired by Pfizer for $179 million after developing an app that can ‘hear’ COVID-19
ASX-listed ResApp developed a smartphone application that studies showed could identify a COVID-19 infection from a person's cough.
Soon you’ll be able to self-diagnose that scratchy throat just by coughing into your smartphone, an Australian startup hopes. The Perth…